Aberdeen Group
ADPT icon

Aberdeen Group’s Adaptive Biotechnologies ADPT Stock Holding History

Aberdeen Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.9M Buy
1,070,627
+24,117
+2% +$384K 0.02% 499
2025
Q4 		$17M Buy
1,046,510
+52,543
+5% +$858K 0.03% 483
2025
Q3 		$14.9M Sell
993,967
-37,092
-4% -$452K 0.02% 527
2025
Q2 		$12M Sell
1,031,059
-166,563
-14% -$1.51M 0.02% 553
2025
Q1 		$8.9M Buy
1,197,622
+193,563
+19% +$1.49M 0.02% 587
2024
Q4 		$6.02M Sell
1,004,059
-25,388
-2% -$140K 0.01% 617
2024
Q3 		$5.27M Hold
1,029,447
– – 0.01% 639
2024
Q2 		$3.73M Hold
1,029,447
– – 0.01% 681
2024
Q1 		$3.3M Buy
1,029,447
+95,653
+10% +$370K 0.01% 728
2023
Q4 		$4.58M Buy
+933,794
New +$4.26M 0.01% 684

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return